Observational studyBreast cancer (Tokyo, Japan)2024

Real-world data of HER2-negative early breast cancer patients treated with anthracycline and/or taxane regimens in Japan.

Akihiko Shimomura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.